Press release
Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
Company to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ET LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a
About this update from Orthofix Medical Inc.
[{"type":"text","content":"\nCompany to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ET\n\n\n LEWISVILLE, Texas--(BUSINESS WIRE)--\nOrthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day.\n\n\nInterested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the event passcode 5184023. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com.\n\n\nInternet Posting of Information\n\n\nOrthofix routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.\n\n\nAbout Orthofix\n\n\nOrthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. To learn more, visit Orthofix.com and follow on LinkedIn.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20250128865236/en/\n\nInvestor Relations\nJulie Dewey, IRC\nChief Investor Relations & Communications Officer\[email protected]\n209.613.6945\n\n\nMedia Relations\nDenise Landry\[email protected]\n214.937.2529\n\n\nSource: Orthofix Medical Inc.","length":4800,"tagName":"div"}]